239 related articles for article (PubMed ID: 10634623)
1. L-Arginine-nitric oxide pathway-related metabolites in the aqueous humor of diabetic patients.
Hattenbach LO; Allers A; Klais C; Koch F; Hecker M
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):213-7. PubMed ID: 10634623
[TBL] [Abstract][Full Text] [Related]
2. Altered L-arginine/nitric oxide synthase/nitric oxide pathway in the vascular adventitia of rats with sepsis.
Jia YX; Pan CS; Yang JH; Liu XH; Yuan WJ; Zhao J; Tang CS; Qi YF
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1202-8. PubMed ID: 17184502
[TBL] [Abstract][Full Text] [Related]
3. Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway.
Shen LJ; Beloussow K; Shen WC
Biochem Pharmacol; 2005 Jan; 69(1):97-104. PubMed ID: 15588718
[TBL] [Abstract][Full Text] [Related]
4. Increased nitric oxide (NO) pathway metabolites in the vitreous fluid of patients with rhegmatogenous retinal detachment or diabetic traction retinal detachment.
Diederen RM; La Heij EC; Deutz NE; Kessels AG; van Eijk HM; Hendrikse F
Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):683-8. PubMed ID: 16267670
[TBL] [Abstract][Full Text] [Related]
5. Effect of ocular hypertension on retinal nitridergic pathway activity.
Belforte N; Moreno MC; Cymeryng C; Bordone M; Keller Sarmiento MI; Rosenstein RE
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2127-33. PubMed ID: 17460271
[TBL] [Abstract][Full Text] [Related]
6. Decreased plasma concentrations of L-hydroxy-arginine as a marker of reduced NO formation in patients with combined cardiovascular risk factors.
Garlichs CD; Beyer J; Zhang H; Schmeisser A; Plötze K; Mügge A; Schellong S; Daniel WG
J Lab Clin Med; 2000 May; 135(5):419-25. PubMed ID: 10811058
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of oxidative-antioxidative status and the L-arginine-nitric oxide pathway in asthmatic patients.
Ceylan E; Aksoy N; Gencer M; Vural H; Keles H; Selek S
Respir Med; 2005 Jul; 99(7):871-6. PubMed ID: 15939249
[TBL] [Abstract][Full Text] [Related]
8. Alternative nitric oxide-producing substrates for NO synthases.
Mansuy D; Boucher JL
Free Radic Biol Med; 2004 Oct; 37(8):1105-21. PubMed ID: 15451052
[TBL] [Abstract][Full Text] [Related]
9. Substrate specificity of NO synthases: detailed comparison of L-arginine, homo-L-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-L-arginine.
Moali C; Boucher JL; Sari MA; Stuehr DJ; Mansuy D
Biochemistry; 1998 Jul; 37(29):10453-60. PubMed ID: 9671515
[TBL] [Abstract][Full Text] [Related]
10. [L-arginine in the lacrimal fluid of patients with diabetic retinopathy and the possible role of nitric oxide in the pathogenesis of retinal ischemia].
Arkhipova MM; Neroev VV; Baratova LA; Lysenko VS
Vestn Oftalmol; 2000; 116(2):23-4. PubMed ID: 11055219
[TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
12. Plasma and aqueous humor angiotensin-converting enzyme levels in patients with diabetic retinopathy.
Aydin E; Demir HD; Sahin S
Curr Eye Res; 2010 Mar; 35(3):230-4. PubMed ID: 20373882
[TBL] [Abstract][Full Text] [Related]
13. Disorders of the blood-aqueous barrier after phacoemulsification in diabetic patients.
Liu Y; Luo L; He M; Liu X
Eye (Lond); 2004 Sep; 18(9):900-4. PubMed ID: 15017379
[TBL] [Abstract][Full Text] [Related]
14. Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy.
Tashimo A; Mitamura Y; Nagai S; Nakamura Y; Ohtsuka K; Mizue Y; Nishihira J
Diabet Med; 2004 Dec; 21(12):1292-7. PubMed ID: 15569131
[TBL] [Abstract][Full Text] [Related]
15. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy.
Shinoda K; Ishida S; Kawashima S; Wakabayashi T; Uchita M; Matsuzaki T; Takayama M; Shinmura K; Yamada M
Curr Eye Res; 2000 Aug; 21(2):655-61. PubMed ID: 11148602
[TBL] [Abstract][Full Text] [Related]
16. [A clinical investigation on the relationship between nitric oxide and elevation of intraocular pressure in glaucoma].
Han Y; Zhang B; Guo X; Zhang Z
Zhonghua Yan Ke Za Zhi; 2001 Jul; 37(4):281-3. PubMed ID: 11864438
[TBL] [Abstract][Full Text] [Related]
17. Recombinant arginine deiminase reduces inducible nitric oxide synthase iNOS-mediated neurotoxicity in a coculture of neurons and microglia.
Yu HH; Wu FL; Lin SE; Shen LJ
J Neurosci Res; 2008 Oct; 86(13):2963-72. PubMed ID: 18627024
[TBL] [Abstract][Full Text] [Related]
18. Complementary distribution of NADPH-diaphorase and l-arginine in the snail nervous system.
Xie M; Hermann A; Kerschbaum HH
Cell Tissue Res; 2002 Mar; 307(3):393-400. PubMed ID: 11904776
[TBL] [Abstract][Full Text] [Related]
19. [Nitric oxide level in aqueous humor in patients with glaucoma].
Kosior-Jarecka E; Gerkowicz M; Latalska M; Kozioł-Montewka M; Szczepanik A
Klin Oczna; 2004; 106(1-2 Suppl):158-9. PubMed ID: 15510482
[TBL] [Abstract][Full Text] [Related]
20. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Selley ML
J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
